BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

Overview Fund Activity

21 hedge funds and large institutions have $5.9M invested in ProShares Ultra NASDAQ Biotechnology in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
-4
Holders Change %
-16%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
7
Closed
7
Calls
$849K
Puts
$1.52M
Net Calls
-$672K
Net Calls Change
-$859K

Top Buyers

1
TRCT
Tower Research Capital (TRC)
New York
$310K
2
Citadel Advisors
Citadel Advisors
Florida
$576K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$482K
4
HIIFS
Harel Insurance Investments & Financial Services
Israel
$9K
5
Morgan Stanley
Morgan Stanley
New York
$20K

Top Sellers

1
IMC Chicago
IMC Chicago
Illinois
$0
2
JF
Jump Financial
Illinois
$393K
3
Jane Street
Jane Street
New York
$0
4
PAG
Private Advisor Group
New Jersey
$0
5
PWM
Palumbo Wealth Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CG
26
Cutler Group
California
– -$20K -400 Closed
GEA
27
Glen Eagle Advisors
New Jersey
– -$781 -15 Closed
NC
28
NewSquare Capital
Pennsylvania
– -$260 -5 Closed
1
2